US FDA concludes audit at Indoco’s Goa Plant I with six 483s
The company will respond to these observations within the stipulated time of 15 days
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
PHARMACONNECT 2019 held in Mumbai
Discussions at the conference touched upon every aspect of India’s pharmaceutical supply chain
Surecom Media’s annual flagship…
GM hens pave way for cheaper cancer drugs
Just three eggs were enough to produce a clinically relevant dose of the drug
Servier, Neurochlore launch phase 3 studies to evaluate bumetanide in children suffering from ASD
Servier has obtained the required authorisations to conduct these clinical trials in France, Spain, Hungary, Germany, Italy,…
Manufacturer to pay penalty for entire batch if single drug found substandard: Govt
According to a government official, the new provision, proposed by the Central Drugs Standard Control Organisation (CDSCO) for…
Cipla receives final approval for Medroxyprogesterone Injectable
The drug, a progestin, is indicated only for the prevention of pregnancy
GSKCH India gets CCI approval for merger deal with HUL
The scheme of amalgamation between the two companies was approved through an-all equity deal, valuing the total business of HUL at…
Natco Pharma to invest ₹ 100 cr for setting up agrichemical facilities in AP
The company expects the facilities to be commissioned by the end of 2019
Indoco posts ₹ 248 crore revenue at Q3 FY19
Aditi Panandikar, MD, Indoco Remedies, expects the business performance to start looking up from the next financial year
Biocon posts revenue of ₹1,566 crore at Q3FY19
The net profit is reported at ₹ 217 crore, up 136 per cent